Relation of Leptin Gene Polymorphism to the Circulating Leptin, Insulin, Estradiol, and Progesterone Hormones in Mares with High Rump Fat

Equine metabolic syndrome is a growing concern usually associated with increased insulin and leptin concentrations. To investigate the relations of obesity determined by measuring the rump fat (RF) with ovarian hormones, leptin, and leptin gene polymorphism, cyclic mares (n=36) were categorized based on RF thickness estimated by the ultrasonography and body condition score (BCS) into obese (RF>5mm; BCS >5), moderate (RF>3≤5 mm;BCS >3≤5) and lean animals (RF<3mm; BCS<3). The circulating estradiol, progesterone, insulin, and leptin were analyzed. The polymorphism of the leptin gene was performed and compared for obese, moderate and lean mares. Depending on increased RF, the obesity was associated with increased BCS (P<0.0001) and leptin (P<0.0001), insulin (P<0.01), and P4 (P<0.0001). Obese mares of leptin genotype BB had the highest leptin (1146±420 pg/ml), insulin (7.42±0.89 μU/l) and progesterone (22.69±9.34 ng/ml), but minimum estradiol (101±54 pg/ml) concentrations. Mares of leptin genotype AA had the highest RF (P<0.0001). The interaction of leptin genotype and obesity had affected RF and all hormone concentrations with no significant effect on the BCS. In conclusion, obesity in cyclic mares altered ovarian hormones, insulin and leptin concentrations. The hyperleptinemia, and hyperinsulinemia were associated with the leptin genotype BB but neither to the adiposity (RF) nor BCS

Effects of Late Gestational Fetal Exposure to Dexamethasone Administration on the Postnatal Hypothalamus-Pituitary-Adrenal Axis Response to Hypoglycemia in Pigs

Background: Prenatal glucocorticoid administration alters the activity of the fetal hypothalamic-pituitary-adrenocortical axis (HPAA), and correspondingly the adenocorticotropic hormone (ACTH) and cortisol levels after birth. The dosages required for these effects are critically discussed. Activation of the HPAA is related to metabolic syndrome and diabetes mellitus. Hypoglycemia is the classic side effect of antidiabetic treatment. We hypothesized that a low dosage of dexamethasone in late pregnancy alters the HPAA response to hypoglycemia in pigs. Methods: 12 pregnant sows were randomly assigned to two groups which received either a low-dose intramuscular injection (99th and 100th day of gestation) of dexamethasone (0.06 μg/kg body weight) or vehicle. Three months after birth, 18 dexamethasone-treated anaesthetized offspring and 12 control offspring underwent a 75 min hypoglycemic clamp (blood glucose below 4 mmol/L) procedure. Heart rate (HR), blood pressure, ACTH and cortisol levels and body weight (at birth and after three months) were recorded. Results: Dexamethasone-treated animals exhibited significantly elevated ACTH (139.9 ± 12.7 pg/mL) and cortisol (483.1 ± 30.3 nmol/L) levels during hypoglycemia as compared to the control group (41.7 ± 6.5 pg/mL and 257.9 ± 26.7 nmol/L, respectively), as well as an elevated HR (205.5 ± 5.7 bpm) and blood pressure (systolic: 128.6 ± 1.5, diastolic: 85.7 ± 0.7 mmHg) response as compared to the control group (153.2 ± 4.5 bpm; systolic: 118.6 ± 1.6, diastolic: 79.5 ± 1.4 mmHg, respectively; p < 0.001). Conclusions: Low-dose prenatal administration of dexamethasone not only exerts effects on the HPAA (ACTH and cortisol concentration) and vital parameters (HR and diastolic blood pressure) under baseline conditions, but also on ACTH, HR and systolic blood pressure during hypoglycemia